Harmony Biosciences Holdings (HRMY) Assets Average (2020 - 2026)

Harmony Biosciences Holdings (HRMY) has 7 years of Assets Average data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 23.79% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 23.79% YoY), and the FY2025 full-year result was $1.1 billion, up 25.42% from the prior year.
• Assets Average grew to $1.3 billion in Q1 2026, from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.3 billion in Q1 2026 to a low of $448.7 million in Q1 2022.
• A 5-year average of $851.7 million and a median of $829.2 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 59.77% in 2022 and grew 15.6% in 2024, its largest moves.
• Tracing HRMY's Assets Average over 5 years: stood at $658.7 million in 2022, then gained by 20.64% to $794.6 million in 2023, then increased by 21.28% to $963.7 million in 2024, then gained by 28.67% to $1.2 billion in 2025, then advanced by 2.56% to $1.3 billion in 2026.
• Business Quant data shows HRMY's Assets Average at $1.3 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.